Long-term prognostic value of sentinel lymph node tumor burden in survival of melanoma patients.

In the article, the authors present their study on the long-term prognostic value of sentinel lymph node (SLN) tumor burden in the survival of melanoma patients with clinically negative regional lymph nodes. Topics include the recommended early completion lymph node dissection (CLND) for metastatic SLN patients to remove non-sentinel lymph nodes (NSN) and the prognostic value in disease-free survival (DFS) and melanoma-specific survival (MSS).